Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of November

 

Commission file number: 001-32749

 

FRESENIUS MEDICAL CARE AG & Co. KGaA

(Translation of registrant's name into English)

 

Else-Kröner Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                Form 40-F ¨

 

 

 

 

 

 

EXHIBITS

 

The following exhibits are being furnished with this Report:

 

Exhibit 99.1

Convenience translation of the announcement pursuant to sections 246 para. 4 sentence 1, 249 para. 1 sentence 1 German Stock Corporation Act.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATE: November 13, 2023

 

	Fresenius Medical Care AG & Co. KGaA,
	a partnership limited by shares, represented by:
	fresenius medical care management ag, its
	General Partner
	By:	/s/ Helen Giza
	Name:	Helen Giza
	Title:	Chief Executive Officer, Chair of the Management Board of the General Partner and Acting Chief Financial Officer
	By:	/s/ Martin Fischer
	Name:	Martin Fischer
	Title:	Chief Financial Officer and member of the Management Board of the General Partner

 

 

 

 

Exhibit 99.1

 

Fresenius Medical Care AG & Co. KGaA

 

Hof

 

ISIN: DE0005785802 // WKN: 578580
ISIN: US3580291066 // CUSIP: 358029106

 

Announcement pursuant to
sections 246 para. 4 sentence 1, 249 para. 1 sentence 1
German Stock Corporation Act (Aktiengesetz)

 

Pursuant to sections 246 para. 4 sentence 1, 249 para. 1 sentence 1 German Stock Corporation Act (Aktiengesetz), we announce that another action for contestation and annulment (Anfechtungs- und Nichtigkeitsklage) has been filed against the resolution adopted at the extraordinary general meeting of Fresenius Medical Care AG & Co. KGaA on July 14, 2023 regarding agenda item 1 (resolution on the conversion of the company into the legal form of a stock corporation). This action has been filed before the Regional Court of Frankfurt a.M. (Landgericht Frankfurt a.M.), 5^th Chamber for Commercial Matters (5. Kammer für Handelssachen), and has been pending (ist rechtshängig) under file number 3-05 O 539/23 since November 3, 2023.

 

Hof, this November 2023

 

Fresenius Medical Care AG & Co. KGaA

 

The General Partner
Fresenius Medical Care Management AG

 

The Management Board

 

 

 

---